Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

RAPPRAPP
6 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in RAPPORT THERAPEUTICS INC

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 644,082 shares of RAPP (RAPPORT THERAPEUTICS INC), worth $26.8M as of 2026-Q2. The position was decreased (-29.9% shares). RAPP represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.

Current Value

$26.8M

Current Shares

644,082

Total Value Change

+$24.8M

Total Shares Change

+440,840

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
644,082
-29.9%
$26.8M0.0%$41.67
0
2026-Q1
Decreased
918,866
-3.5%
$28.8M0.0%$27.85
0
2025-Q4
Increased
952,371
+6.7%
$28.9M0.0%$30.64
31
2025-Q3
Increased
892,258
+265.9%
$26.5M0.0%$27.97
46
2025-Q2
Increased
243,880
+20.0%
$2.8M0.0%$11.43
31
2025-Q1
New
203,242
-
$2M0.0%$10.05
36

Other major holders of RAPP: FMR LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used